Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Ophthalmology

  Free Subscription


Articles published in J Ocul Pharmacol Ther

Retrieve available abstracts of 198 articles:
HTML format



Single Articles


    June 2020
  1. LU LJ, Chen X, Adelman RA
    Clinical Etiologies, Microbial Spectrum, Antibiotic Susceptibilities, and Visual Acuity Outcomes of Acute Endophthalmitis.
    J Ocul Pharmacol Ther. 2020 Jun 29. doi: 10.1089/jop.2018.0074.
    PubMed     Abstract available


  2. JUNCAL VR, Mak MYK, Bamakrid M, Muni RH, et al
    Changes in Aqueous Cytokine Levels Following Intravitreal Aflibercept in Treatment-Naive Patients with Diabetic Macular Edema.
    J Ocul Pharmacol Ther. 2020 Jun 24. doi: 10.1089/jop.2020.0038.
    PubMed     Abstract available


  3. PATIL MA, Kompella UB
    Noninvasive Monitoring of Choroid-Retina Autofluorescence and Intravitreal Nanoparticle Disposition in Royal College of Surgeon Rats of Different Ages and Retinal Thinning.
    J Ocul Pharmacol Ther. 2020 Jun 18. doi: 10.1089/jop.2020.0028.
    PubMed     Abstract available


  4. NAVARRO-PARTIDA J, Altamirano-Vallejo JC, Lopez-Naranjo EJ, Gonzalez-De la Rosa A, et al
    Topical Triamcinolone Acetonide-Loaded Liposomes as Primary Therapy for Macular Edema Secondary to Branch Retinal Vein Occlusion: A Pilot Study.
    J Ocul Pharmacol Ther. 2020 Jun 17. doi: 10.1089/jop.2019.0143.
    PubMed     Abstract available


  5. KIM JH, Kim JW, Kim CG, Lee DW, et al
    Decreased Periodicity of Reactivation Interval in Neovascular Age-Related Macular Degeneration in Patients with a Late First Reactivation After Initial Treatment.
    J Ocul Pharmacol Ther. 2020 Jun 17. doi: 10.1089/jop.2019.0158.
    PubMed     Abstract available


  6. KABASHIMA K, Murakami A, Ebihara N
    Effects of Benzalkonium Chloride and Preservative-Free Composition on the Corneal Epithelium Cells.
    J Ocul Pharmacol Ther. 2020 Jun 17. doi: 10.1089/jop.2019.0165.
    PubMed     Abstract available


  7. LIN Z, Huang S, Yu H, Sun J, et al
    Analysis of Plasma Hydrogen Sulfide, Homocysteine, and L-Cysteine in Open-Angle Glaucoma Patients.
    J Ocul Pharmacol Ther. 2020 Jun 3. doi: 10.1089/jop.2020.0023.
    PubMed     Abstract available


  8. DAULL P, Amrane M, Ismail D, Georgiev G, et al
    Cationic Emulsion-Based Artificial Tears as a Mimic of Functional Healthy Tear Film for Restoration of Ocular Surface Homeostasis in Dry Eye Disease.
    J Ocul Pharmacol Ther. 2020 Jun 3. doi: 10.1089/jop.2020.0011.
    PubMed     Abstract available


    May 2020
  9. AKSOY M, Yilmaz G, Vardarli I, Akkoyun I, et al
    Choroidal Thickness After Dexamethasone Implant or Aflibercept in Patients with Diabetic Macular Edema Persistent to Ranibizumab.
    J Ocul Pharmacol Ther. 2020 May 27. doi: 10.1089/jop.2020.0004.
    PubMed     Abstract available


  10. NOVACK GD, Barnett M
    Ocular Drug Delivery Systems Using Contact Lenses.
    J Ocul Pharmacol Ther. 2020 May 25. doi: 10.1089/jop.2020.0024.
    PubMed     Abstract available


  11. KUTLUTURK KARAGOZ I, Allahverdiyev A, Bagirova M, Abamor ES, et al
    Current Approaches in Treatment of Diabetic Retinopathy and Future Perspectives.
    J Ocul Pharmacol Ther. 2020 May 21. doi: 10.1089/jop.2019.0137.
    PubMed     Abstract available


  12. KAHRAMAN NS, Oner A
    Effect of Transcorneal Electrical Stimulation on Patients with Retinitis Pigmentosa.
    J Ocul Pharmacol Ther. 2020 May 19. doi: 10.1089/jop.2020.0017.
    PubMed     Abstract available


  13. AL SABAANI N
    Kaempferol Protects Against Hydrogen Peroxide-Induced Retinal Pigment Epithelium Cell Inflammation and Apoptosis by Activation of SIRT1 and Inhibition of PARP1.
    J Ocul Pharmacol Ther. 2020 May 15. doi: 10.1089/jop.2019.0151.
    PubMed     Abstract available


  14. LEE JY, Lee SY, Kim JY, Lee HJ, et al
    Effect of Alternate Treatment with Intravitreal Anti-Vascular Endothelial Growth Factor and Steroid for Treatment-Naive Diabetic Macular Edema in a Real-Life Setting.
    J Ocul Pharmacol Ther. 2020 May 12. doi: 10.1089/jop.2020.0012.
    PubMed     Abstract available


  15. CHUMSAKUL O, Wakayama K, Tsuhako A, Baba Y, et al
    Apigenin Regulates Activation of Microglia and Counteracts Retinal Degeneration.
    J Ocul Pharmacol Ther. 2020 May 5. doi: 10.1089/jop.2019.0163.
    PubMed     Abstract available


    April 2020
  16. EL-MOFTY HM, El-Nabarawi MA, Abd El Rehem RT, Teaima MH, et al
    Niosomes: Do They Increase the Potency of Topical Natamycin Ketorolac Formula in Treating Aspergillus Keratitis? An Experimental Study.
    J Ocul Pharmacol Ther. 2020 Apr 30. doi: 10.1089/jop.2019.0128.
    PubMed     Abstract available


  17. ZHAO X, Wang X, Zu W, Chen S, et al
    An UPLC-MS/MS Method for Simultaneous Determination of Tropicamide and Phenylephrine in Rabbit Ocular Tissues and Plasma.
    J Ocul Pharmacol Ther. 2020 Apr 22. doi: 10.1089/jop.2019.0152.
    PubMed     Abstract available


  18. PATIL A, Lakhani P, Taskar P, Avula B, et al
    Carboxyvinyl Polymer and Guar-Borate Gelling System Containing Natamycin Loaded PEGylated Nanolipid Carriers Exhibit Improved Ocular Pharmacokinetic Parameters.
    J Ocul Pharmacol Ther. 2020 Apr 21. doi: 10.1089/jop.2019.0140.
    PubMed     Abstract available


  19. DURGUN ME, Gungor S, Ozsoy Y
    Micelles: Promising Ocular Drug Carriers for Anterior and Posterior Segment Diseases.
    J Ocul Pharmacol Ther. 2020 Apr 20. doi: 10.1089/jop.2019.0109.
    PubMed     Abstract available


  20. ZHOU T, Miao Y, Li Z, Lu P, et al
    A Comparative Ocular Pharmacokinetics Study of Preservative-Free Latanoprost Unit-Dose Eye Drops and a Benzalkonium Chloride-Preserved Branded Product Following Topical Application to Rabbits.
    J Ocul Pharmacol Ther. 2020 Apr 20. doi: 10.1089/jop.2019.0102.
    PubMed     Abstract available


  21. USTUNDAG OKUR N, Caglar ES, Siafaka PI
    Novel Ocular Drug Delivery Systems: An Update on Microemulsions.
    J Ocul Pharmacol Ther. 2020 Apr 7. doi: 10.1089/jop.2019.0135.
    PubMed     Abstract available


  22. KANSARA V, Muya L, Wan CR, Ciulla TA, et al
    Suprachoroidal Delivery of Viral and Nonviral Gene Therapy for Retinal Diseases.
    J Ocul Pharmacol Ther. 2020 Apr 7. doi: 10.1089/jop.2019.0126.
    PubMed     Abstract available


  23. CAVDARLI C, Topcu Yilmaz P
    Pupil Diameter, Corneal Thickness, and Anterior Chamber Alterations Following Topical Olopatadine Hydrochloride 0.1%: A Single-Masked Randomized Controlled Clinical Study.
    J Ocul Pharmacol Ther. 2020 Apr 3. doi: 10.1089/jop.2020.0007.
    PubMed     Abstract available


  24. WEINREB RN, Robinson MR, Dibas M, Stamer WD, et al
    Matrix Metalloproteinases and Glaucoma Treatment.
    J Ocul Pharmacol Ther. 2020 Apr 1. doi: 10.1089/jop.2019.0146.
    PubMed     Abstract available


    March 2020
  25. GAO S, Lin Z, Chen Y, Xu J, et al
    Intravitreal Conbercept Injection as an Adjuvant in Vitrectomy with Silicone Oil Infusion for Severe Proliferative Diabetic Retinopathy.
    J Ocul Pharmacol Ther. 2020 Mar 18. doi: 10.1089/jop.2019.0149.
    PubMed     Abstract available


  26. VOLLMER TR, Zhou EH, Rice DS, Prasanna G, et al
    Application of Cell Impedance as a Screening Tool to Discover Modulators of Intraocular Pressure.
    J Ocul Pharmacol Ther. 2020 Mar 13. doi: 10.1089/jop.2019.0078.
    PubMed     Abstract available


  27. MARUYAMA Y, Ikeda Y, Mori K, Yoshii K, et al
    Safety and Efficacy of Long-Term Ripasudil 0.4% Instillation for the Reduction of Intraocular Pressure in Japanese Open-Angle Glaucoma Patients.
    J Ocul Pharmacol Ther. 2020 Mar 12. doi: 10.1089/jop.2019.0125.
    PubMed     Abstract available


  28. MOLOKHIA S, Papangkorn K, Butler C, Higuchi JW, et al
    Transscleral Iontophoresis for Noninvasive Ocular Drug Delivery of Macromolecules.
    J Ocul Pharmacol Ther. 2020 Mar 5. doi: 10.1089/jop.2019.0081.
    PubMed     Abstract available



  29. Correction to: Development of High-Resolution Three-Dimensional-Printed Extracellular Matrix Scaffolds and Their Compatibility with Pluripotent Stem Cells and Early Retinal Cells, by Shrestha, A., Allen, B.N., Wiley, L.A. Tucker, B.A., and Worthington
    J Ocul Pharmacol Ther. 2020;36:133.
    PubMed    


    February 2020
  30. BAYRAKTUTAR BN, Hamrah P
    Response to McMonnies and Young Re: "ISOPT Clinical Hot Topic Panel Discussion on Cornea Anterior Segment Disease" by Asbell et al. (J Ocul Pharmacol Ther 2019;35:447-456).
    J Ocul Pharmacol Ther. 2020 Feb 19. doi: 10.1089/jop.2020.29064.
    PubMed    


  31. MCMONNIES CW, Young N
    Re: "ISOPT Clinical Hot Topic Panel Discussion on Cornea Anterior Segment Disease" by Asbell et al. (J Ocul Pharmacol Ther 2019;35:447-456).
    J Ocul Pharmacol Ther. 2020 Feb 19. doi: 10.1089/jop.2019.0129.
    PubMed    


  32. STORM T, Wilson I, Campbell R, Bolinches-Amoros A, et al
    A Semiautomated, Phenotypic, In Vitro Scratch Assay for Assessing Retinal Pigment Epithelial Cell Wound Healing.
    J Ocul Pharmacol Ther. 2020 Feb 6. doi: 10.1089/jop.2019.0116.
    PubMed     Abstract available


  33. KAYIRAN CELEBIER S, Bozdag Pehlivan S, Demirbilek M, Akinci M, et al
    Development of an Anti-Inflammatory Drug-Incorporated Biomimetic Scaffold for Corneal Tissue Engineering.
    J Ocul Pharmacol Ther. 2020 Feb 5. doi: 10.1089/jop.2019.0114.
    PubMed     Abstract available


    January 2020
  34. YEH PT, Chen YJ, Lin NC, Yeh AI, et al
    The Ocular Protective Effects of Nano/Submicron Particles Prepared from Lycium barbarum Fruits Against Oxidative Stress in an Animal Model.
    J Ocul Pharmacol Ther. 2020 Jan 16. doi: 10.1089/jop.2019.0048.
    PubMed     Abstract available


  35. ZANDI S, Freiberg F, Vaclavik V, Pfister IB, et al
    Morphological Reconstitution and Persistent Changes After Intravitreal Ocriplasmin for Vitreomacular Traction and Macular Hole.
    J Ocul Pharmacol Ther. 2020 Jan 14. doi: 10.1089/jop.2019.0051.
    PubMed     Abstract available


  36. CHEN X, Lee S, Zhang T, Duan T, et al
    Nanomolar Potency Aminophenyltriazine CFTR Activator Reverses Corneal Epithelial Injury in a Mouse Model of Dry Eye.
    J Ocul Pharmacol Ther. 2020 Jan 14. doi: 10.1089/jop.2019.0087.
    PubMed     Abstract available



  37. Correction to: New Therapies to Reduce Intraocular Pressure, by Konda, S.M. and Kaufman, P.L. J Ocul Pharmacol Ther 2019;35(6):322-324. DOI: 10.1089/jop.2019.0059.
    J Ocul Pharmacol Ther. 2020;36:70-71.
    PubMed    


    December 2019
  38. VERITTI D, Sarao V, De Nadai K, Chizzolini M, et al
    Dexamethasone Implant Produces Better Outcomes than Oral Acetazolamide in Patients with Cystoid Macular Edema Secondary to Retinitis Pigmentosa.
    J Ocul Pharmacol Ther. 2019 Dec 30. doi: 10.1089/jop.2018.0153.
    PubMed     Abstract available


  39. MACCARONE R, Tisi A, Passacantando M, Ciancaglini M, et al
    Ophthalmic Applications of Cerium Oxide Nanoparticles.
    J Ocul Pharmacol Ther. 2019 Dec 5. doi: 10.1089/jop.2019.0105.
    PubMed     Abstract available


  40. GUO L, Fan L, Tao J, Hua R, et al
    Use of Topical 0.01% Atropine for Controlling Near Work-Induced Transient Myopia: A Randomized, Double-Blinded, Placebo-Controlled Study.
    J Ocul Pharmacol Ther. 2019 Dec 3. doi: 10.1089/jop.2019.0062.
    PubMed     Abstract available


  41. CRUPI R, Impellizzeri D, Gugliandolo E, Cordaro M, et al
    Effect of Tempol, a Membrane-Permeable Free Radical Scavenger, on In Vitro Model of Eye Inflammation on Rabbit Corneal Cells.
    J Ocul Pharmacol Ther. 2019;35:571-577.
    PubMed     Abstract available


    November 2019

  42. Correction to: ISOPT Clinical Hot Topic Panel Discussion on Glaucoma, by Blumenthal, E.Z, Cordeiro, M.F., Schmetterer, L. Verbin, H.L., and Harris, A. J Ocul Pharmacol Ther 2019;35(8):441-446. DOI: 10.1089/jop.2019.0004.
    J Ocul Pharmacol Ther. 2019 Nov 27. doi: 10.1089/jop.2019.0004.
    PubMed    


  43. KOROL A, Kustryn T, Zadorozhnyy O, Pasyechnikova N, et al
    Comparison of Efficacy of Intravitreal Ranibizumab and Aflibercept in Eyes with Myopic Choroidal Neovascularization: 24-Month Follow-Up.
    J Ocul Pharmacol Ther. 2019 Nov 22. doi: 10.1089/jop.2019.0080.
    PubMed     Abstract available


  44. PEREZ VL, Wirostko B, Korenfeld M, From S, et al
    Ophthalmic Drug Delivery Using Iontophoresis: Recent Clinical Applications.
    J Ocul Pharmacol Ther. 2019 Nov 22. doi: 10.1089/jop.2019.0034.
    PubMed     Abstract available


  45. WU P, Shi D, Chen X, Feng C, et al
    Long-Term Efficacy of Intravitreal Conbercept Injection in the Treatment of Idiopathic Choroidal Neovascularization.
    J Ocul Pharmacol Ther. 2019 Nov 21. doi: 10.1089/jop.2019.0075.
    PubMed     Abstract available


  46. AIHARA M, Lu F, Kawata H, Tanaka Y, et al
    Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study).
    J Ocul Pharmacol Ther. 2019 Nov 1. doi: 10.1089/jop.2019.0044.
    PubMed     Abstract available



  47. Correction to: In Vitro Evaluation of Hybrid Cooperative Complexes of Hyaluronic Acid as a Potential New Ophthalmic Treatment, by La Gatta, A., Corsuto, L., Salzillo, R., D'Agostino, A., De Rosa, M., Bracco, A., and Schiraldi, C. J Ocul Pharmacol Ther
    J Ocul Pharmacol Ther. 2019;35:522.
    PubMed    


    October 2019
  48. OZDEMIR MH, Elbay A, Kirik F, Ekinci C, et al
    Regression of Serous Macular Detachment After Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema.
    J Ocul Pharmacol Ther. 2019 Oct 24. doi: 10.1089/jop.2019.0028.
    PubMed     Abstract available


  49. SEVEN E, Yildiz S, Tekin S, Altas AS, et al
    Effect of Insulin Therapy on Ocular Biometric Parameters in Diabetic Patients.
    J Ocul Pharmacol Ther. 2019 Oct 23. doi: 10.1089/jop.2019.0070.
    PubMed     Abstract available


  50. GRZYBOWSKI A, Brockmann T, Kanclerz P, Pleyer U, et al
    Dexamethasone Intraocular Suspension: A Long-Acting Therapeutic for Treating Inflammation Associated with Cataract Surgery.
    J Ocul Pharmacol Ther. 2019 Oct 23. doi: 10.1089/jop.2019.0072.
    PubMed     Abstract available


  51. SINGHAL R, Luo A, O'Rourke T, Scott IU, et al
    Transzonular Triamcinolone-Moxifloxacin Versus Topical Drops for the Prophylaxis of Postoperative Inflammation After Cataract Surgery.
    J Ocul Pharmacol Ther. 2019 Oct 15. doi: 10.1089/jop.2019.0097.
    PubMed     Abstract available


  52. BEZZINA AD, Carbonaro F
    Factors Predicting Treatment Response in Anti-Vascular Endothelial Growth Factor Naive Diabetic Macular Edema Patients Treated with Intravitreal Bevacizumab.
    J Ocul Pharmacol Ther. 2019 Oct 11. doi: 10.1089/jop.2018.0112.
    PubMed     Abstract available


  53. MAZZILLI JL, Snook JD, Simmons K, Domozhirov AY, et al
    A Preclinical Safety Study of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells for Macular Degeneration.
    J Ocul Pharmacol Ther. 2019 Oct 9. doi: 10.1089/jop.2019.0039.
    PubMed     Abstract available


  54. KLARLUND JK, Callaghan JD, Stella NA, Kowalski RP, et al
    Use of Collagen Binding Domains to Deliver Molecules to the Cornea.
    J Ocul Pharmacol Ther. 2019 Oct 9. doi: 10.1089/jop.2019.0065.
    PubMed     Abstract available


  55. JAYAGOPAL A, Ragelle H
    Introduction to JOPT Special Issue: Next-Generation Tissue Engineering-Inspired Models for Ophthalmic Drug Discovery.
    J Ocul Pharmacol Ther. 2019 Oct 1. doi: 10.1089/jop.2019.0101.
    PubMed    


  56. BLUMENTHAL EZ, Cordeiro MF, Shmetterer L, Levkovitch Verbin H, et al
    ISOPT Clinical Hot Topic Panel Discussion on Glaucoma.
    J Ocul Pharmacol Ther. 2019;35:441-446.
    PubMed     Abstract available


  57. NEUMANN R, Nguyen QD, Kramer M, Zierhut M, et al
    ISOPT Clinical Hot Topic Panel Discussion on Uveitis and Inflammation.
    J Ocul Pharmacol Ther. 2019;35:433-440.
    PubMed     Abstract available


  58. ASBELL PA, Aquavella JV, Hamrah P, Pepose JS, et al
    ISOPT Clinical Hot Topic Panel Discussion on Cornea Anterior Segment Disease.
    J Ocul Pharmacol Ther. 2019;35:447-456.
    PubMed     Abstract available


  59. KUPPERMANN BD, Bernstein P, Mones J, Do DV, et al
    ISOPT Clinical Hot Topic Panel Discussion on Medical Treatment of Retinal Diseases.
    J Ocul Pharmacol Ther. 2019;35:424-432.
    PubMed     Abstract available


    September 2019
  60. VALERA-CORNEJO DA, Vega-Estrada A, Alio JL
    Invasive Pharmacology Outcomes with Different Corneal Cross-Linking Protocols: A Review.
    J Ocul Pharmacol Ther. 2019 Sep 24. doi: 10.1089/jop.2018.0144.
    PubMed     Abstract available


  61. GONZALEZ-DE LA ROSA A, Navarro-Partida J, Altamirano-Vallejo JC, Jauregui-Garcia GD, et al
    Novel Triamcinolone Acetonide-Loaded Liposomal Topical Formulation Improves Contrast Sensitivity Outcome After Femtosecond Laser-Assisted Cataract Surgery.
    J Ocul Pharmacol Ther. 2019 Sep 5. doi: 10.1089/jop.2019.0032.
    PubMed     Abstract available


    August 2019
  62. UCHIDA T, Ueta T, Honjo M, Aihara M, et al
    The Neuroprotective Effect of the Adiponectin Receptor Agonist AdipoRon on Glutamate-Induced Cell Death in Rat Primary Retinal Ganglion Cells.
    J Ocul Pharmacol Ther. 2019 Aug 28. doi: 10.1089/jop.2018.0152.
    PubMed     Abstract available


  63. SHRESTHA A, Allen BN, Wiley LA, Tucker BA, et al
    Development of High-Resolution Three-Dimensional-Printed Extracellular Matrix Scaffolds and Their Compatibility with Pluripotent Stem Cells and Early Retinal Cells.
    J Ocul Pharmacol Ther. 2019 Aug 16. doi: 10.1089/jop.2018.0146.
    PubMed     Abstract available


  64. MATSUSHIMA R, Noma H, Yasuda K, Goto H, et al
    Role of Cytokines in Ranibizumab Therapy for Macular Edema in Patients with Central Retinal Vein Occlusion.
    J Ocul Pharmacol Ther. 2019 Aug 2. doi: 10.1089/jop.2019.0011.
    PubMed     Abstract available


  65. SALIMI A, Winter A, Li C, Harasymowycz P, et al
    Effect of Topical Corticosteroids on Early Postoperative Intraocular Pressure Following Combined Cataract and Trabecular Microbypass Surgery.
    J Ocul Pharmacol Ther. 2019 Aug 2. doi: 10.1089/jop.2019.0019.
    PubMed     Abstract available


  66. HWANG HB, Kim SY, Ohn K, Kim SY, et al
    Histopathologic Analysis of Conjunctival Lymphoproliferative Disease After Topical Brimonidine Use.
    J Ocul Pharmacol Ther. 2019 Aug 2. doi: 10.1089/jop.2019.0037.
    PubMed     Abstract available


  67. SMYTH-MEDINA R, Johnston J, Devries DK, Jasper A, et al
    Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Conjunctival Staining in Patients with Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and 3 Clinical Trials.
    J Ocul Pharmacol Ther. 2019 Aug 2. doi: 10.1089/jop.2018.0154.
    PubMed     Abstract available


    July 2019
  68. WEISS SL, Kramer WG
    Ocular Distribution of Cyclosporine Following Topical Administration of OTX-101 in New Zealand White Rabbits.
    J Ocul Pharmacol Ther. 2019 Jul 29. doi: 10.1089/jop.2018.0106.
    PubMed     Abstract available


    June 2019
  69. PLUSS CJ, Kustermann S
    A Human Three-Dimensional In Vitro Model of Lens Epithelial Cells as a Model to Study Mechanisms of Drug-Induced Posterior Subcapsular Cataracts.
    J Ocul Pharmacol Ther. 2019 Jun 28. doi: 10.1089/jop.2019.0010.
    PubMed     Abstract available


  70. CRUL M, Zandvliet A, Moes JR, Veenbaas T, et al
    Bevacizumab for Intravitreal Injection: Impact of Sub-Visible Particles on the Shelf-Life of Repackaged Bevacizumab.
    J Ocul Pharmacol Ther. 2019 Jun 28. doi: 10.1089/jop.2019.0042.
    PubMed     Abstract available


  71. SIMSEK C, Dogru M, Shinzawa M, Den S, et al
    The Efficacy of 2% Topical Rebamipide on Conjunctival Squamous Metaplasia and Goblet Cell Density in Dry Eye Disease.
    J Ocul Pharmacol Ther. 2019 Jun 28. doi: 10.1089/jop.2018.0130.
    PubMed     Abstract available


  72. KOMPELLA UB, Domb A, Urtti A, Jayagopal A, et al
    Ocular Drug Delivery: Nanotechnology, Physical and Chemical Methods, Vitreous Drug Binding, and Aging Eye.
    J Ocul Pharmacol Ther. 2019 Jun 28. doi: 10.1089/jop.2018.0138.
    PubMed     Abstract available


  73. TAKHAR JS, Pawar VK, Marneris AG, Doan TA, et al
    When to Consider Bisphosphonates in Patients on Steroids for Chronic Ocular Inflammatory Conditions.
    J Ocul Pharmacol Ther. 2019 Jun 26. doi: 10.1089/jop.2019.0058.
    PubMed    


  74. LABETOULLE M, Rousseau A, M'Garrech M, Kaswin G, et al
    Efficacy of a Topical Heparan Sulfate Mimetic Polymer on Ocular Surface Discomfort in Patients with Cogan's Epithelial Basement Membrane Dystrophy.
    J Ocul Pharmacol Ther. 2019 Jun 21. doi: 10.1089/jop.2019.0015.
    PubMed     Abstract available


  75. KONDA SM, Kaufman PL
    New Therapies to Reduce Intraocular Pressures.
    J Ocul Pharmacol Ther. 2019 Jun 20. doi: 10.1089/jop.2019.0059.
    PubMed    


  76. SERNA-OJEDA JC, Santana-Cruz O, Quiroz-Casian N, Gonzalez-Mendoza E, et al
    Pain Management in Corneal Collagen Crosslinking for Keratoconus: A Comparative Case Series.
    J Ocul Pharmacol Ther. 2019 Jun 19. doi: 10.1089/jop.2019.0021.
    PubMed     Abstract available


  77. FENTON OS, Paolini M, Andresen JL, Muller FJ, et al
    Outlooks on Three-Dimensional Printing for Ocular Biomaterials Research.
    J Ocul Pharmacol Ther. 2019 Jun 18. doi: 10.1089/jop.2018.0142.
    PubMed     Abstract available


  78. WRIGHT CB, Becker SM, Low LA, Tagle DA, et al
    Improved Ocular Tissue Models and Eye-On-A-Chip Technologies Will Facilitate Ophthalmic Drug Development.
    J Ocul Pharmacol Ther. 2019 Jun 5. doi: 10.1089/jop.2018.0139.
    PubMed     Abstract available


    May 2019
  79. RAGELLE H, Goncalves A, Kustermann S, Antonetti DA, et al
    Organ-On-A-Chip Technologies for Advanced Blood-Retinal Barrier Models.
    J Ocul Pharmacol Ther. 2019 May 29. doi: 10.1089/jop.2019.0017.
    PubMed     Abstract available


  80. LI C, Feng X, Wen X, Li Y, et al
    A Pilot Clinical Study of Intravitreal Injection of Artesunate for Ocular Neovascularization.
    J Ocul Pharmacol Ther. 2019 May 15. doi: 10.1089/jop.2018.0097.
    PubMed     Abstract available


  81. SEBBAG L, Yan Y, Smith JS, Allbaugh RA, et al
    Tear Fluid Pharmacokinetics Following Oral Prednisone Administration in Dogs With and Without Conjunctivitis.
    J Ocul Pharmacol Ther. 2019 May 9. doi: 10.1089/jop.2019.0020.
    PubMed     Abstract available


  82. PERAGINE C, Walker SAN, Walker S, Palmay L, et al
    Fluoroquinolone Antibiotic Prophylaxis to Prevent Post-Traumatic Bacterial Infectious Endophthalmitis: Using Monte Carlo Simulation to Evaluate the Probability of Success.
    J Ocul Pharmacol Ther. 2019 May 8. doi: 10.1089/jop.2019.0013.
    PubMed     Abstract available


  83. AASEN DM, Vergara MN
    New Drug Discovery Paradigms for Retinal Diseases: A Focus on Retinal Organoids.
    J Ocul Pharmacol Ther. 2019 May 6. doi: 10.1089/jop.2018.0140.
    PubMed     Abstract available


    April 2019
  84. CHO YK, Shin EY, Uehara H, Ambati B, et al
    Antiangiogenesis Effect of Albendazole on the Cornea.
    J Ocul Pharmacol Ther. 2019 Apr 27. doi: 10.1089/jop.2018.0103.
    PubMed     Abstract available


  85. WOODWARD DF, Wang JW, Coleman RA, Woodrooffe AJ, et al
    A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method.
    J Ocul Pharmacol Ther. 2019 Apr 25. doi: 10.1089/jop.2018.0126.
    PubMed     Abstract available


  86. TASKAR P, Adelli G, Patil A, Lakhani P, et al
    Analog Derivatization of Cannabidiol for Improved Ocular Permeation.
    J Ocul Pharmacol Ther. 2019 Apr 18. doi: 10.1089/jop.2018.0141.
    PubMed     Abstract available


  87. YANG L, Qiu Y, Liu J, Lin R, et al
    Retinal Transcriptome Analysis in the Treatment of Endotoxin-Induced Uveitis with Tetramethylpyrazine Eye Drops.
    J Ocul Pharmacol Ther. 2019 Apr 17. doi: 10.1089/jop.2018.0105.
    PubMed     Abstract available


  88. BANTSEEV V, Miller PE, Nork TM, Rasmussen CA, et al
    Determination of a No Observable Effect Level for Endotoxin Following a Single Intravitreal Administration to Cynomolgus Monkeys.
    J Ocul Pharmacol Ther. 2019 Apr 9. doi: 10.1089/jop.2018.0149.
    PubMed     Abstract available


  89. ABDEL-MEGUID AAE, Gabr AF, Said MM, Hamid Nassef MAE, et al
    Comparative Study Between Topical Gatifloxacin 0.5% and Moxifloxacin 0.5% as a Prophylactic Measure Before Intraocular Surgery.
    J Ocul Pharmacol Ther. 2019 Apr 5. doi: 10.1089/jop.2018.0088.
    PubMed     Abstract available


    March 2019
  90. BROWN GC, Brown MM
    Patient Preference-Based Comparative Effectiveness and Cost-Utility Analysis of the Prostamides for Open-Angle Glaucoma.
    J Ocul Pharmacol Ther. 2019 Mar 28. doi: 10.1089/jop.2018.0114.
    PubMed     Abstract available


  91. HAN DP, Skumatz C, Besharse JC, Kassem IS, et al
    Sustained Anti-Vascular Endothelial Growth Factor Activity of Aflibercept (Eylea) After Storage in Polycarbonate Syringes Used for Intravitreal Injection: A Pathway to Safety and Efficiency.
    J Ocul Pharmacol Ther. 2019 Mar 27. doi: 10.1089/jop.2018.0085.
    PubMed     Abstract available


  92. CAVET ME, Glogowski S, Lowe ER, Phillips E, et al
    Rheological Properties, Dissolution Kinetics, and Ocular Pharmacokinetics of Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38.
    J Ocul Pharmacol Ther. 2019 Mar 23. doi: 10.1089/jop.2018.0136.
    PubMed     Abstract available


  93. WOLFRAM C, Stahlberg E, Pfeiffer N
    Patient-Reported Nonadherence with Glaucoma Therapy.
    J Ocul Pharmacol Ther. 2019 Mar 21. doi: 10.1089/jop.2018.0134.
    PubMed     Abstract available


  94. WANG T, Li W, Zhong L, Ye H, et al
    Evaluation of the Effects of Biohcly in an In Vivo Model of Mechanical Wounds in the Rabbit Cornea.
    J Ocul Pharmacol Ther. 2019 Mar 19. doi: 10.1089/jop.2018.0098.
    PubMed     Abstract available


  95. ITAKURA T, Webster A, Chintala SK, Wang Y, et al
    GPR158 in the Visual System: Homeostatic Role in Regulation of Intraocular Pressure.
    J Ocul Pharmacol Ther. 2019 Mar 11. doi: 10.1089/jop.2018.0135.
    PubMed     Abstract available


    February 2019
  96. CHO HJ, Jung SH, Cho S, Han JO, et al
    Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Pachychoroid Neovasculopathy.
    J Ocul Pharmacol Ther. 2019 Feb 26. doi: 10.1089/jop.2018.0107.
    PubMed     Abstract available


  97. TEKIN S, Seven E, Batur M
    Evaluation of Antiglaucomatous Drops on Conjunctival Thickness in Patients with Primary Open-Angle Glaucoma.
    J Ocul Pharmacol Ther. 2019 Feb 13. doi: 10.1089/jop.2018.0124.
    PubMed     Abstract available


    January 2019
  98. LEE SS, Dibas M, Almazan A, Robinson MR, et al
    Dose-Response of Intracameral Bimatoprost Sustained-Release Implant and Topical Bimatoprost in Lowering Intraocular Pressure.
    J Ocul Pharmacol Ther. 2019 Jan 30. doi: 10.1089/jop.2018.0095.
    PubMed     Abstract available


  99. GEORGAKOPOULOS CD, Plotas P, Kagkelaris K, Tsapardoni F, et al
    Analgesic Effect of a Single Drop of Nepafenac 0.3% on Pain Associated with Intravitreal Injections: A Randomized Clinical Trial.
    J Ocul Pharmacol Ther. 2019 Jan 28. doi: 10.1089/jop.2018.0113.
    PubMed     Abstract available


  100. ARBABI A, Liu A, Ameri H
    Gene Therapy for Inherited Retinal Degeneration.
    J Ocul Pharmacol Ther. 2019 Jan 28. doi: 10.1089/jop.2018.0087.
    PubMed     Abstract available


  101. NELSON WW, Lima AF, Kranyak J, Opong-Owusu B, et al
    Retrospective Medical Record Review to Describe Use of Repository Corticotropin Injection Among Patients with Uveitis in the United States.
    J Ocul Pharmacol Ther. 2019 Jan 24. doi: 10.1089/jop.2018.0090.
    PubMed     Abstract available


  102. YANG KB, Zhang H, Li SJ, Cao JJ, et al
    Conbercept and Ranibizumab Pretreatments in Vitrectomy with Silicone Oil Infusion for Severe Diabetic Retinopathy.
    J Ocul Pharmacol Ther. 2019 Jan 22. doi: 10.1089/jop.2018.0093.
    PubMed     Abstract available


  103. SAMY KE, Cao Y, Kim J, Konichi da Silva NR, et al
    Co-Delivery of Timolol and Brimonidine with a Polymer Thin-Film Intraocular Device.
    J Ocul Pharmacol Ther. 2019 Jan 7. doi: 10.1089/jop.2018.0096.
    PubMed     Abstract available


  104. GONZALEZ-DE LA ROSA A, Navarro-Partida J, Altamirano-Vallejo JC, Hernandez-Gamez AG, et al
    Novel Triamcinolone Acetonide-Loaded Liposomes Topical Formulation for the Treatment of Cystoid Macular Edema After Cataract Surgery: A Pilot Study.
    J Ocul Pharmacol Ther. 2019 Jan 7. doi: 10.1089/jop.2018.0101.
    PubMed     Abstract available


  105. CHUA PY, Clare G, Leslie T
    Re: "The Efficacy and Safety of the Fixed Combination of Brinzolamide 1% and Brimonidine 0.2% in Normal Tension Glaucoma: An 18-Month Retrospective Study" by Jin and Lee (J. Ocul. Pharmacol. Ther. 34:274-279, 2018).
    J Ocul Pharmacol Ther. 2019;35:3-4.
    PubMed    


  106. JIN SW
    Response to Chua et al. re: "The Efficacy and Safety of the Fixed Combination of Brinzolamide 1% and Brimonidine 0.2% in Normal Tension Glaucoma: An 18-Month Retrospective Study".
    J Ocul Pharmacol Ther. 2019;35:5.
    PubMed    


  107. RODIER JT, Tripathi R, Fink MK, Sharma A, et al
    Linear Polyethylenimine-DNA Nanoconstruct for Corneal Gene Delivery.
    J Ocul Pharmacol Ther. 2019;35:23-31.
    PubMed     Abstract available



  108. Correction to: Efficacy and Safety of 0.6% Pazufloxacin Ophthalmic Solution Versus Moxifloxacin 0.5% and Gatifloxacin 0.3% in Subjects with Bacterial Conjunctivitis: A Randomized Clinical Trial, by Baiza-Duran, L., Olvera-Montano, O., Mercado-Sesma, A
    J Ocul Pharmacol Ther. 2019;35:76.
    PubMed    


    December 2018
  109. ZHANG J, Zhou K, Zhang X, Zhou Y, et al
    Celastrol Ameliorates Inflammation in Human Retinal Pigment Epithelial Cells by Suppressing NF-kappaB Signaling.
    J Ocul Pharmacol Ther. 2018 Dec 31. doi: 10.1089/jop.2018.0092.
    PubMed     Abstract available


  110. YATES KA, Shanks RMQ, Kowalski RP, Romanowski EG, et al
    The In Vitro Evaluation of Povidone-Iodine Against Multiple Ocular Adenoviral Types.
    J Ocul Pharmacol Ther. 2018 Dec 27. doi: 10.1089/jop.2018.0122.
    PubMed     Abstract available


  111. WOODWARD DF, Wang JW, Ni M, Bauer AJ, et al
    In Vivo Choroidal Neovascularization and Macrophage Studies Provide Further Evidence for a Broad Role of Prostacyclin in Angiogenesis.
    J Ocul Pharmacol Ther. 2018 Dec 14. doi: 10.1089/jop.2018.0077.
    PubMed     Abstract available


    November 2018
  112. RANGARAJAN R, Ketelson H
    Preclinical Evaluation of a New Hydroxypropyl-Guar Phospholipid Nanoemulsion-Based Artificial Tear Formulation in Models of Corneal Epithelium.
    J Ocul Pharmacol Ther. 2018 Nov 29. doi: 10.1089/jop.2018.0031.
    PubMed     Abstract available


  113. CALLANAN D, Kunimoto D, Maturi RK, Patel SS, et al
    Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration.
    J Ocul Pharmacol Ther. 2018 Nov 9. doi: 10.1089/jop.2018.0062.
    PubMed     Abstract available


  114. EKANAYAKA SA, McClellan SA, Peng X, Barrett RP, et al
    HMGB1 Antagonist, Box A, Reduces TLR4, RAGE, and Inflammatory Cytokines in the Cornea of P. aeruginosa-Infected Mice.
    J Ocul Pharmacol Ther. 2018 Nov 8. doi: 10.1089/jop.2018.0073.
    PubMed     Abstract available


  115. LAKHANI P, Patil A, Majumdar S
    Challenges in the Polyene- and Azole-Based Pharmacotherapy of Ocular Fungal Infections.
    J Ocul Pharmacol Ther. 2018 Nov 8. doi: 10.1089/jop.2018.0089.
    PubMed     Abstract available


  116. HOUBEN I, De Zaeytijd J, Deghislage C, Frost NA, et al
    Efficacy of Multiple Dexamethasone Intravitreal Implants for Refractory Retinal Vein Occlusion-Related Macular Edema and Effect of Prior Vitrectomy.
    J Ocul Pharmacol Ther. 2018 Nov 7. doi: 10.1089/jop.2018.0012.
    PubMed     Abstract available


    October 2018
  117. CELIKER H, Kazokoglu H, Direskeneli H
    Factors Affecting Relapse and Remission in Behcet's Uveitis Treated with Interferon Alpha2a.
    J Ocul Pharmacol Ther. 2018 Oct 25. doi: 10.1089/jop.2018.0083.
    PubMed     Abstract available


  118. REE YS, Back HM, Yun HY, Ahn JH, et al
    Dose Optimization Based on Population Pharmacokinetic Modeling of High-Dose Cyclosporine, a P-glycoprotein Inhibitor, in Combination with Systemic Chemotherapy in Pediatric Patients with Retinoblastoma.
    J Ocul Pharmacol Ther. 2018 Oct 18. doi: 10.1089/jop.2018.0041.
    PubMed     Abstract available


  119. SZEGEDI S, Scheschy U, Schmidl D, Aranha Dos Santos V, et al
    Effect of Single Instillation of Two Hyaluronic Acid-Based Topical Lubricants on Tear Film Thickness in Patients with Dry Eye Syndrome.
    J Ocul Pharmacol Ther. 2018 Oct 16. doi: 10.1089/jop.2018.0069.
    PubMed     Abstract available


  120. LA GATTA A, Corsuto L, Salzillo R, D'Agostino A, et al
    In Vitro Evaluation of Hybrid Cooperative Complexes of Hyaluronic Acid as a Potential New Ophthalmic Treatment.
    J Ocul Pharmacol Ther. 2018 Oct 16. doi: 10.1089/jop.2018.0046.
    PubMed     Abstract available


  121. MOON I, Kang HG, Yeo A, Noh H, et al
    Comparison of Ocular Surface Mucin Expression After Topical Ophthalmic Drug Administration in Dry Eye-Induced Mouse Model.
    J Ocul Pharmacol Ther. 2018 Oct 16. doi: 10.1089/jop.2018.0005.
    PubMed     Abstract available


  122. GOLDSTEIN AS, Aldrich BT, Skeie JM, Schmidt GA, et al
    Assessing the Effects of Ripasudil, a Novel Rho Kinase Inhibitor, on Human Corneal Endothelial Cell Health.
    J Ocul Pharmacol Ther. 2018 Oct 12. doi: 10.1089/jop.2018.0063.
    PubMed     Abstract available


  123. DAULL P, Raymond E, Feraille L, Garrigue JS, et al
    Safety and Tolerability of Overdosed Artificial Tears by Abraded Rabbit Corneas.
    J Ocul Pharmacol Ther. 2018 Oct 12. doi: 10.1089/jop.2018.0040.
    PubMed     Abstract available


  124. CHUN YH, Beak JU, Kim HS, Na KS, et al
    Topical Cyclosporine Pretreatment of Ocular Surface in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
    J Ocul Pharmacol Ther. 2018 Oct 5. doi: 10.1089/jop.2018.0006.
    PubMed     Abstract available


    September 2018
  125. TORIYAMA K, Suzuki T, Shiraishi A
    Characteristics of Infectious Keratitis in Old and Very Old Patients.
    J Ocul Pharmacol Ther. 2018 Sep 15. doi: 10.1089/jop.2018.0028.
    PubMed     Abstract available


  126. YOON CH, Park JW, Ryu JS, Kim MK, et al
    Corneal Toxicity of Topical Tacrolimus Ointment in Mice with Corneal Epithelial Injury.
    J Ocul Pharmacol Ther. 2018 Sep 15. doi: 10.1089/jop.2018.0054.
    PubMed     Abstract available


  127. BOZIC M, Stojkovic M, Knezevic M, Marjanovic I, et al
    Is the Use of Refrigerated Fixed Combination of Dorzolamide 2%-Timolol 0.5% (COSOPT) Associated with Less Ocular Discomfort? A Pilot Study.
    J Ocul Pharmacol Ther. 2018 Sep 11. doi: 10.1089/jop.2018.0023.
    PubMed     Abstract available


  128. SEIBOLD LK, Wagner BD, Lynch AM, Kahook MY, et al
    The Diurnal and Nocturnal Effects of Pilocarpine on Intraocular Pressure in Patients Receiving Prostaglandin Analog Monotherapy.
    J Ocul Pharmacol Ther. 2018 Sep 7. doi: 10.1089/jop.2018.0050.
    PubMed     Abstract available


  129. WILL-ORREGO A, Qiu Y, Fassbender ES, Shen S, et al
    Amount of Mononuclear Phagocyte Infiltrate Does Not Predict Area of Experimental Choroidal Neovascularization (CNV).
    J Ocul Pharmacol Ther. 2018;34:489-499.
    PubMed     Abstract available


    August 2018
  130. GADE SK, Shivshetty N, Sharma N, Bhatnagar S, et al
    Effect of Mucoadhesive Polymeric Formulation on Corneal Permeation of Fluoroquinolones.
    J Ocul Pharmacol Ther. 2018 Aug 23. doi: 10.1089/jop.2018.0059.
    PubMed     Abstract available


  131. REZKALLAH A, Malcles A, Dot C, Voirin N, et al
    Evaluation of Efficacy and Safety of Dexamethasone Intravitreal Implants of Vitrectomized and Nonvitrectomized Eyes in a Real-World Study.
    J Ocul Pharmacol Ther. 2018 Aug 17. doi: 10.1089/jop.2018.0007.
    PubMed     Abstract available


  132. GARCIA-FEIJOO J, Hoh H, Uzunov R, Dickerson JE Jr, et al
    Supraciliary Microstent in Refractory Open-Angle Glaucoma: Two-Year Outcomes from the DUETTE Trial.
    J Ocul Pharmacol Ther. 2018 Aug 3. doi: 10.1089/jop.2018.0036.
    PubMed     Abstract available


    July 2018
  133. LIN YC, Horng LY, Sung HC, Wu RT, et al
    Sodium Iodate Disrupted the Mitochondrial-Lysosomal Axis in Cultured Retinal Pigment Epithelial Cells.
    J Ocul Pharmacol Ther. 2018 Jul 18. doi: 10.1089/jop.2017.0073.
    PubMed     Abstract available


  134. FRAUNFELDER FT, Fraunfelder FW
    Oral Anti-Vascular Endothelial Growth Factor Drugs and Ocular Side Effects.
    J Ocul Pharmacol Ther. 2018 Jul 13. doi: 10.1089/jop.2018.0019.
    PubMed     Abstract available


  135. FUWA M, Toris CB, Fan S, Taniguchi T, et al
    Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys.
    J Ocul Pharmacol Ther. 2018 Jul 10. doi: 10.1089/jop.2017.0146.
    PubMed     Abstract available


  136. AIHARA M
    Response to Novack re: "Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes".
    J Ocul Pharmacol Ther. 2018;34:431.
    PubMed    


    June 2018
  137. GUIMARAES DE SOUZA R, Yu Z, Stern ME, Pflugfelder SC, et al
    Suppression of Th1-Mediated Keratoconjunctivitis Sicca by Lifitegrast.
    J Ocul Pharmacol Ther. 2018 Jun 29. doi: 10.1089/jop.2018.0047.
    PubMed     Abstract available


  138. NOVACK GD
    Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes.
    J Ocul Pharmacol Ther. 2018 Jun 20. doi: 10.1089/jop.2018.0048.
    PubMed    


    May 2018
  139. KAKIMOTO H, Takamura Y, Arimura S, Miyake S, et al
    Effect of 0.05% Difluprednate Ophthalmic Emulsion on Proinflammatory Cytokine Levels After Retinal Laser Photocoagulation in Rabbits.
    J Ocul Pharmacol Ther. 2018 May 29. doi: 10.1089/jop.2017.0109.
    PubMed     Abstract available


  140. ZHAO X, Tong Y, Wang X, Zhang X, et al
    Comparison of the Ocular Penetration and Pharmacokinetics Between Natamycin and Voriconazole After Topical Instillation in Rabbits.
    J Ocul Pharmacol Ther. 2018 May 24. doi: 10.1089/jop.2017.0139.
    PubMed     Abstract available


  141. CHAKRAVARTI T
    The Association of Socioeconomic Status with Severity of Glaucoma and the Impacts of Both Factors on the Costs of Glaucoma Medications: A Cross-Sectional Study in West Bengal, India.
    J Ocul Pharmacol Ther. 2018 May 15. doi: 10.1089/jop.2017.0135.
    PubMed     Abstract available


  142. CHO YK, Shin EY, Uehara H, Ambati B, et al
    The Effect of 0.5% Timolol Maleate on Corneal(Lymph)Angiogenesis in a Murine Suture Model.
    J Ocul Pharmacol Ther. 2018 May 14. doi: 10.1089/jop.2017.0119.
    PubMed     Abstract available


  143. TRAN HDM, Tran YH, Tran TD, Jong M, et al
    A Review of Myopia Control with Atropine.
    J Ocul Pharmacol Ther. 2018 May 1. doi: 10.1089/jop.2017.0144.
    PubMed     Abstract available


    April 2018
  144. SMITH A, Pawar M, Van Dort ME, Galban S, et al
    Ocular Toxicity Profile of ST-162 and ST-168 as Novel Bifunctional MEK/PI3K Inhibitors.
    J Ocul Pharmacol Ther. 2018 Apr 30. doi: 10.1089/jop.2017.0126.
    PubMed     Abstract available


  145. GARAY-ARAMBURU G, Gomez-Moreno A
    A 5-Year Follow-Up Study of the Treatment of Macular Edema Due to Retinal Vein Occlusion Using Dexamethasone Intravitreal Implants.
    J Ocul Pharmacol Ther. 2018 Apr 30. doi: 10.1089/jop.2017.0148.
    PubMed     Abstract available


  146. BAIZA-DURAN L, Olvera-Montano O, Mercado-Sesma AR, Oregon-Miranda AA, et al
    Efficacy and Safety of 0.6% Pazufloxacin Ophthalmic Solution Versus Moxifloxacin 0.5% and Gatifloxacin 0.5% in Subjects with Bacterial Conjunctivitis: A Randomized Clinical Trial.
    J Ocul Pharmacol Ther. 2018;34:250-255.
    PubMed     Abstract available


    March 2018
  147. RUANGVARAVATE N, Prabhasawat P, Vachirasakchai V, Tantimala R, et al
    High Prevalence of Ocular Surface Disease Among Glaucoma Patients in Thailand.
    J Ocul Pharmacol Ther. 2018 Mar 29. doi: 10.1089/jop.2017.0104.
    PubMed     Abstract available


  148. ZHU S, Xu X, Liu K, Gu Q, et al
    PAPep Inhibits Secretion of Poly(I:C)-Induced Inflammatory Cytokines and ICAM-1 Expression in Corneal Fibroblasts by Suppressing the NF-kappaB/p38 Pathway.
    J Ocul Pharmacol Ther. 2018 Mar 27. doi: 10.1089/jop.2017.0068.
    PubMed     Abstract available


    February 2018
  149. NOVACK GD, Moyer ED
    Slit Lamp-Based Ocular Scoring Systems: Commentary.
    J Ocul Pharmacol Ther. 2018 Feb 26. doi: 10.1089/jop.2018.29039.
    PubMed    


  150. KAZEMI A, McLaren JW, Kopczynski CC, Heah TG, et al
    The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans.
    J Ocul Pharmacol Ther. 2018 Feb 22. doi: 10.1089/jop.2017.0138.
    PubMed     Abstract available


  151. OZGONUL C, Dedania VS, Besirli CG
    Aflibercept Versus Bevacizumab and/or Ranibizumab for Recurrent Macular Edema Secondary to Central Retinal Vein Occlusion.
    J Ocul Pharmacol Ther. 2018 Feb 15. doi: 10.1089/jop.2017.0074.
    PubMed     Abstract available


  152. UCAN GUNDUZ G, Parmak Yener N, Kilincel O, Gunduz C, et al
    How Does Usage of Serotonin Noradrenaline Reuptake Inhibitors Affect Intraocular Pressure in Depression Patients?
    J Ocul Pharmacol Ther. 2018 Feb 15. doi: 10.1089/jop.2017.0133.
    PubMed     Abstract available


  153. PAPANGKORN K, Higuchi JW, Brar B, Higuchi WI, et al
    Ocular Drug Distribution and Safety of a Noninvasive Ocular Drug Delivery System of Dexamethasone Sodium Phosphate in Rabbit.
    J Ocul Pharmacol Ther. 2018 Feb 12. doi: 10.1089/jop.2017.0093.
    PubMed     Abstract available


  154. BACHU RD, Stepanski M, Alzhrani RM, Jung R, et al
    Development and Evaluation of a Novel Microemulsion of Dexamethasone and Tobramycin for Topical Ocular Administration.
    J Ocul Pharmacol Ther. 2018 Feb 6. doi: 10.1089/jop.2017.0082.
    PubMed     Abstract available


  155. CARLSON E, Kao WWY, Ogundele A
    Impact of Hyaluronic Acid-Containing Artificial Tear Products on Reepithelialization in an In Vivo Corneal Wound Model.
    J Ocul Pharmacol Ther. 2018 Feb 2. doi: 10.1089/jop.2017.0080.
    PubMed     Abstract available



  156. Correction to: The Effect of Posture on Intraocular Pressure and Systemic Hemodynamic Parameters in Treated and Untreated Patients with Primary Open-Angle Glaucoma, by Katsanos, A., Dastiridou, A.I., Quaranta, L., Rulli, E., Riva, I., Dimasi, V., Tsir
    J Ocul Pharmacol Ther. 2018 Feb 2. doi: 10.1089/jop.2017.0030.
    PubMed    


  157. DINC E, Ayaz L, Kurt AH
    Effects of Bevacizumab, Ranibizumab, and Aflibercept on MicroRNA Expression in a Retinal Pigment Epithelium Cell Culture Model of Oxidative Stress.
    J Ocul Pharmacol Ther. 2018 Feb 1. doi: 10.1089/jop.2017.0128.
    PubMed     Abstract available


  158. YAZICI A, Sari E, Ayhan E, Sahin G, et al
    The Effect of Low-Dose Aspirin on Dry Eye Parameters and Ocular Surface Disease Index Questionnaire.
    J Ocul Pharmacol Ther. 2018 Feb 1. doi: 10.1089/jop.2017.0064.
    PubMed     Abstract available


    January 2018
  159. KARACA ADIYEKE S, Ture G, Talay E
    Intravitreal Dexamethasone Implant for Postvitrectomy Macular Edema: A Retrospective Cohort of 14 Patients (Postvitrectomy Macular Edema Treatment).
    J Ocul Pharmacol Ther. 2018 Jan 29. doi: 10.1089/jop.2017.0107.
    PubMed     Abstract available


  160. NJIE-MBYE YF, Robinson J, Mitchell-Bush L, Mckoy M, et al
    Pharmacology of Serotonin Receptors Causing Contraction of Isolated Bovine Posterior Ciliary Arteries: Role in Ocular Blood Flow.
    J Ocul Pharmacol Ther. 2018 Jan 25. doi: 10.1089/jop.2017.0124.
    PubMed     Abstract available


  161. OHIA SE, Njie-Mbye YF, Robinson J, Mitchell L, et al
    Serotonin-2B/2C Receptors Mediate Bovine Ciliary Muscle Contraction: Role in Intraocular Pressure Regulation.
    J Ocul Pharmacol Ther. 2018 Jan 24. doi: 10.1089/jop.2017.0123.
    PubMed     Abstract available


  162. SINGH S, Agarwal R, Abdul Razak Z, Ngu R, et al
    Ocular Permeation of Topical Tazocin and Its Effectiveness in the Treatment of Pseudomonas aeruginosa Induced Keratitis in Rabbits.
    J Ocul Pharmacol Ther. 2018 Jan 17. doi: 10.1089/jop.2017.0098.
    PubMed     Abstract available


  163. SHARIF NA
    iDrugs and iDevices Discovery Research: Preclinical Assays, Techniques, and Animal Model Studies for Ocular Hypotensives and Neuroprotectants.
    J Ocul Pharmacol Ther. 2018 Jan 11. doi: 10.1089/jop.2017.0125.
    PubMed     Abstract available


  164. SEKINE Y, Shimada M, Satake S, Okubo M, et al
    Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes.
    J Ocul Pharmacol Ther. 2018 Jan 11. doi: 10.1089/jop.2017.0091.
    PubMed     Abstract available


  165. JIN SW, Lee SM
    The Efficacy and Safety of the Fixed Combination of Brinzolamide 1% and Brimonidine 0.2% in Normal Tension Glaucoma: An 18-Month Retrospective Study.
    J Ocul Pharmacol Ther. 2018 Jan 3. doi: 10.1089/jop.2017.0075.
    PubMed     Abstract available


    December 2017
  166. CHUNG JK, Spencer E, Hunt M, McCauley T, et al
    Ocular Distribution and Pharmacokinetics of Lifitegrast in Pigmented Rabbits and Mass Balance in Beagle Dogs.
    J Ocul Pharmacol Ther. 2017 Dec 21. doi: 10.1089/jop.2017.0106.
    PubMed     Abstract available


  167. EKANAYAKA SA, McClellan SA, Barrett RP, Hazlett LD, et al
    Topical Glycyrrhizin Is Therapeutic for Pseudomonas aeruginosa Keratitis.
    J Ocul Pharmacol Ther. 2017 Dec 13. doi: 10.1089/jop.2017.0094.
    PubMed     Abstract available


  168. WATERBURY LD
    Alternative Drug Delivery for Patients Undergoing Cataract Surgery as Demonstrated in a Canine Model.
    J Ocul Pharmacol Ther. 2017 Dec 11. doi: 10.1089/jop.2017.0048.
    PubMed     Abstract available


  169. OHIA SE, Robinson J, Mitchell L, Ngele KK, et al
    Regulation of Aqueous Humor Dynamics by Hydrogen Sulfide: Potential Role in Glaucoma Pharmacotherapy.
    J Ocul Pharmacol Ther. 2017 Dec 7. doi: 10.1089/jop.2017.0077.
    PubMed     Abstract available


  170. SCHMITT HM, Schlamp CL, Nickells RW
    Targeting HDAC3 Activity with RGFP966 Protects Against Retinal Ganglion Cell Nuclear Atrophy and Apoptosis After Optic Nerve Injury.
    J Ocul Pharmacol Ther. 2017 Dec 6. doi: 10.1089/jop.2017.0059.
    PubMed     Abstract available


  171. KHAN S, Warade S, Singhavi DJ
    Improvement in Ocular Bioavailability and Prolonged Delivery of Tobramycin Sulfate Following Topical Ophthalmic Administration of Drug-Loaded Mucoadhesive Microparticles Incorporated in Thermosensitive In Situ Gel.
    J Ocul Pharmacol Ther. 2017 Dec 6. doi: 10.1089/jop.2017.0079.
    PubMed     Abstract available


  172. HARTMAN RR, Kompella UB
    Intravitreal, Subretinal, and Suprachoroidal Injections: Evolution of Microneedles for Drug Delivery.
    J Ocul Pharmacol Ther. 2017 Dec 5. doi: 10.1089/jop.2017.0121.
    PubMed     Abstract available


  173. EATON JS, Miller PE, Bentley E, Thomasy SM, et al
    The SPOTS System: An Ocular Scoring System Optimized for Use in Modern Preclinical Drug Development and Toxicology.
    J Ocul Pharmacol Ther. 2017;33:718-734.
    PubMed     Abstract available


    November 2017
  174. MASUOKA T, Gallar J, Belmonte C
    Inhibitory Effect of Amitriptyline on the Impulse Activity of Cold Thermoreceptor Terminals of Intact and Tear-Deficient Guinea Pig Corneas.
    J Ocul Pharmacol Ther. 2017 Nov 29. doi: 10.1089/jop.2017.0066.
    PubMed     Abstract available


  175. CHEN Y, Hua R
    Therapeutic Efficacy of Conbercept for Inflammatory Choroidal Neovascularization.
    J Ocul Pharmacol Ther. 2017 Nov 29. doi: 10.1089/jop.2017.0097.
    PubMed    


  176. BANTSEEV V, Erickson R, Leipold D, Amaya C, et al
    Nonclinical Safety Assessment of Anti-Factor D: Key Strategies and Challenges for the Nonclinical Development of Intravitreal Biologics.
    J Ocul Pharmacol Ther. 2017 Nov 17. doi: 10.1089/jop.2017.0063.
    PubMed     Abstract available


  177. MIOTTO S, Zemella N, Gusson E, Panozzo G, et al
    Morphologic Criteria of Lesion Activity in Neovascular Age-Related Macular Degeneration: A Consensus Article.
    J Ocul Pharmacol Ther. 2017 Nov 17. doi: 10.1089/jop.2017.0022.
    PubMed     Abstract available


  178. SUWANNOI P, Chomnawang M, Sarisuta N, Reichl S, et al
    Development of Acyclovir-Loaded Albumin Nanoparticles and Improvement of Acyclovir Permeation Across Human Corneal Epithelial T Cells.
    J Ocul Pharmacol Ther. 2017 Nov 7. doi: 10.1089/jop.2017.0057.
    PubMed     Abstract available


  179. EATON JS, Miller PE, Bentley E, Thomasy SM, et al
    Slit Lamp-Based Ocular Scoring Systems in Toxicology and Drug Development: A Literature Survey.
    J Ocul Pharmacol Ther. 2017 Nov 7. doi: 10.1089/jop.2017.0021.
    PubMed     Abstract available


  180. DI ZAZZO A, Roberti G, Mashaghi A, Abud TB, et al
    Use of Topical Cannabinomimetic Palmitoylethanolamide in Ocular Surface Disease Associated with Antiglaucoma Medications.
    J Ocul Pharmacol Ther. 2017;33:670-677.
    PubMed     Abstract available


    October 2017
  181. PAPANGKORN K, Prendergast E, Higuchi JW, Brar B, et al
    Noninvasive Ocular Drug Delivery System of Dexamethasone Sodium Phosphate in the Treatment of Experimental Uveitis Rabbit.
    J Ocul Pharmacol Ther. 2017 Oct 12. doi: 10.1089/jop.2017.0053.
    PubMed     Abstract available


  182. MOUSTAFA MT, Ramirez C, Schneider K, Atilano SR, et al
    Protective Effects of Memantine on Hydroquinone-Treated Human Retinal Pigment Epithelium Cells and Human Retinal Muller Cells.
    J Ocul Pharmacol Ther. 2017;33:610-619.
    PubMed     Abstract available


    September 2017
  183. GARWEG JG, Niderprim SA, Russ HM, Pfister IB, et al
    Comparison of Strategies of Treatment with Ranibizumab in Newly-Diagnosed Cases of Neovascular Age-Related Macular Degeneration.
    J Ocul Pharmacol Ther. 2017 Sep 27. doi: 10.1089/jop.2017.0006.
    PubMed     Abstract available


  184. LIN CJ, Chen HS, Su CW, Tien PT, et al
    The Effect of Age and Initial Central Retinal Thickness on Earlier Need of Repeat Ozurdex Treatment for Macular Edema Due to Retinal Vein Occlusion: A Retrospective Case Series.
    J Ocul Pharmacol Ther. 2017 Sep 26. doi: 10.1089/jop.2017.0070.
    PubMed     Abstract available


  185. CORCORAN P, Hollander DA, Ousler GW 3rd, Angjeli E, et al
    Dynamic Sensitivity of Corneal TRPM8 Receptors to Menthol Instillation in Dry Eye Versus Normal Subjects.
    J Ocul Pharmacol Ther. 2017.
    PubMed     Abstract available


  186. GUERRA M, Marques S, Quadrado Gil J, Campos J, et al
    Neurotrophic Keratopathy: Therapeutic Approach Using a Novel Matrix Regenerating Agent.
    J Ocul Pharmacol Ther. 2017.
    PubMed     Abstract available


    July 2017
  187. PENG SY, Lai CC, Wang NK, Wu WC, et al
    Real-World Experience with Half-Time Versus Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy.
    J Ocul Pharmacol Ther. 2017;33:466-472.
    PubMed     Abstract available


    June 2017
  188. BARANOV P, Lin H, McCabe K, Gale D, et al
    A Novel Neuroprotective Small Molecule for Glial Cell Derived Neurotrophic Factor Induction and Photoreceptor Rescue.
    J Ocul Pharmacol Ther. 2017;33:412-422.
    PubMed     Abstract available


  189. ROLANDO M, Vagge A
    Safety and Efficacy of Cortisol Phosphate in Hyaluronic Acid Vehicle in the Treatment of Dry Eye in Sjogren Syndrome.
    J Ocul Pharmacol Ther. 2017;33:383-390.
    PubMed     Abstract available


  190. SANCHEZ-AVILA RM, Merayo-Lloves J, Riestra AC, Anitua E, et al
    The Effect of Immunologically Safe Plasma Rich in Growth Factor Eye Drops in Patients with Sjogren Syndrome.
    J Ocul Pharmacol Ther. 2017;33:391-399.
    PubMed     Abstract available


    May 2017
  191. TERADA Y, Kamoi K, Komizo T, Miyata K, et al
    Human T Cell Leukemia Virus Type 1 and Eye Diseases.
    J Ocul Pharmacol Ther. 2017;33:216-223.
    PubMed     Abstract available


  192. WEI JR, Wen X, Bible PW, Li Z, et al
    Panax Notoginseng Saponin Controls IL-17 Expression in Helper T Cells.
    J Ocul Pharmacol Ther. 2017;33:285-289.
    PubMed     Abstract available


    April 2017
  193. RUBSAM A, Thieme CE, Schlomberg J, Winterhalter S, et al
    Therapy Rationale for Mineralocorticoid-Receptor Antagonists, Acetazolamide and a Switch of Therapy in Nonresponders in Central Serous Chorioretinopathy.
    J Ocul Pharmacol Ther. 2017;33:141-148.
    PubMed     Abstract available


  194. SELEN F, Tekeli O, Yanik O
    Assessment of the Anterior Chamber Flare and Macular Thickness in Patients Treated with Topical Antiglaucomatous Drugs.
    J Ocul Pharmacol Ther. 2017;33:170-175.
    PubMed     Abstract available


    March 2017
  195. BAO X, Hou M, Qin Y, Luo F, et al
    Effect of an MG132-Sustained Drug Delivery Capsular Ring on the Inhibition of Posterior Capsule Opacification in a Rabbit Model.
    J Ocul Pharmacol Ther. 2017;33:103-110.
    PubMed     Abstract available


  196. TORKILDSEN G, Abelson MB, Gomes PJ, McLaurin E, et al
    Vehicle-Controlled, Phase 2 Clinical Trial of a Sustained-Release Dexamethasone Intracanalicular Insert in a Chronic Allergen Challenge Model.
    J Ocul Pharmacol Ther. 2017;33:79-90.
    PubMed     Abstract available


  197. PARK Y, Song JS, Choi CY, Yoon KC, et al
    A Randomized Multicenter Study Comparing 0.1%, 0.15%, and 0.3% Sodium Hyaluronate with 0.05% Cyclosporine in the Treatment of Dry Eye.
    J Ocul Pharmacol Ther. 2017;33:66-72.
    PubMed     Abstract available


    January 2017
  198. PFLUGFELDER SC, Stern M, Zhang S, Shojaei A, et al
    LFA-1/ICAM-1 Interaction as a Therapeutic Target in Dry Eye Disease.
    J Ocul Pharmacol Ther. 2017;33:5-12.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ophthalmology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: